The in vitro effect of oxidized LDL and PHA on proliferation and gene expression of regulatory T cells in patients with atherosclerosis

Iranian Journal of Allergy, Asthma and Immunology

Volumn 11, Issue 3, 2012, Pages 217-223

  Mottaghi, Azadeh ^a   Salehi, Eisa ^a   Sezavar, Hashem ^b   Keshavarz, Seyed Ali ^a   Eshraghian, Mohammad Reza ^a   Rezaei, Nima ^b,c   Rejali, Leili ^d   Saboor Yaraghi, Ali Akbar ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Atherosclerosis; Gene expression; Ox LDL; Peripheral blood mononuclear cells; T regulatory cells

Indexed keywords

OXIDIZED LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOXP3 GENE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHYTOHEMAGGLUTININ GENE; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; TRANSFORMING GROWTH FACTOR BETA GENE;

ADULT; AGED; ATHEROSCLEROSIS; CASE-CONTROL STUDIES; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PHYTOHEMAGGLUTININS; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 84865972258     PISSN: 17351502     EISSN: 17355249     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Ait-Oufella H, Taleb S, Mallat Z, Tedgui A. Cytokine network and T cell immunity in atherosclerosis. Semin Immunopathol 2009; 31(1):23-33.
2. Mahmoudi M, Siassi F, Mahmoudi MJ, Eshraghian MR, Zarnani AH, Rezaei N, et al. Defective T-cell proliferation and IL-2 production in a subgroup of patients with coronary artery disease. Iran J Allergy Asthma Immunol 2010; 9(3):133-40.
3. Mahmoudi MJ, Hedayat M, Rezaei N, Saboor-Yaraghi AA, Mahmoudi M. In vitro soluble CD30 levels in patients with chronic stable coronary artery disease. Iran J Allergy Asthma Immunol 2011; 8(4):237-42.
4. Fei GZ, Huang YH, Swedenborg J, Frostegard J. Oxidised LDL modulates immune-activation by an IL-12 dependent mechanism. Atherosclerosis 2003; 169(1):77-85. (Pubitemid 36830925)
5. Caspar-Bauguil S, Saadawi M, Negre-Salvayre A, Thomsen M, Salvayre R, Benoist H. Mildly oxidized low-density lipoproteins suppress the proliferation of activated CD4+ T-lymphocytes and their interleukin 2 receptor expression in vitro. Biochem J 1998; 330 (Pt 2):659-66. (Pubitemid 28111959)
6. Fortun A, Khalil A, Gagne D, Douziech N, Kuntz C, Jay-Gerin JP, et al. Monocytes influence the fate of T cells challenged with oxidised low density lipoproteins towards apoptosis or MHC-restricted proliferation. Atherosclerosis 2001; 156(1):11-21. (Pubitemid 32429590)
7. Libby P, Hansson GK. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest 1991; 64(1):5-15.
8. Salvayre R, Auge N, Benoist H, Negre-Salvayre A. Oxidized low-density lipoprotein-induced apoptosis. Biochim Biophys Acta 2002; 1585(2-3):213-21. (Pubitemid 36092085)
9. Xiao S, Jin H, Korn T, Liu SM, Oukka M, Lim B, et al. Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J Immunol 2008; 181(4):2277-84.
10. Cheng X, Yu X, Ding YJ, Fu QQ, Xie JJ, Tang TT, et al. The Th17/Treg imbalance in patients with acute coronary syndrome. Clin Immunol 2008; 127(1):89-97.
11. de Boer OJ, van der Meer JJ, Teeling P, van der Loos CM, van der Wal AC. Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions. PLoS One 2007; 2(8):e779.
12. Ait-Oufella H, Salomon BL, Potteaux S, Robertson AK, Gourdy P, Zoll J, et al. Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med 2006; 12(2):178-80. (Pubitemid 43214743)
13. Mallat Z, Ait-Oufella H, Tedgui A. Regulatory T cell responses: potential role in the control of atherosclerosis. Curr Opin Lipidol 2005; 16(5):518-24. (Pubitemid 41376901)
14. Mor A, Planer D, Luboshits G, Afek A, Metzger S, Chajek-Shaul T, et al. Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis. Arterioscler Thromb Vasc Biol 2007; 27(4):893-900. (Pubitemid 46606722)
15. Mor A, Luboshits G, Planer D, Keren G, George J. Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes. Eur Heart J 2006; 27(21):2530-7. (Pubitemid 44627295)
16. Frostegard J, Wu R, Giscombe R, Holm G, Lefvert AK, Nilsson J. Induction of T-cell activation by oxidized low density lipoprotein. Arterioscler Thromb 1992; 12(4):461-7.
17. Mahmoudi MJ, Mahmoudi M, Siassi F, Shokri F, Eshraghian MR, Zarnani AH, et al. Lymphocyte cytotoxicity of oxLDL in patients with atherosclerosis. Iran J Immunol 2011; 8(1):27-33.
18. Lee KC, Wong M, Spitzer D. Chloroquine as a probe for antigen processing by accessory cells. Transplantation 1982; 34(3):150-3. (Pubitemid 12056810)
19. Smith DA, Irving SD, Sheldon J, Cole D, Kaski JC. Serum levels of the antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation 2001; 104(7):746-9. (Pubitemid 32762668)
20. Heeschen C, Dimmeler S, Hamm CW, Fichtlscherer S, Boersma E, Simoons ML, et al. Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 2003; 107(16):2109-14. (Pubitemid 36532192)
21. Blasi C. The autoimmune origin of atherosclerosis. Atherosclerosis, 2008; 201(1):17-32.
22. Ni Choileain N, Redmond HP. Regulatory T-cells and autoimmunity. J Surg Res 2006; 130(1):124-35. (Pubitemid 43028574)
23. Randolph DA, Fathman CG. Cd4+Cd25+ regulatory T cells and their therapeutic potential. Annu Rev Med 2006; 57:381-402. (Pubitemid 43261997)
24. Sakaguchi S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 2000; 101(5):455-8.
25. Mallat Z, Ait-Oufella H, Tedgui A. Regulatory T-cell immunity in atherosclerosis. Trends Cardiovasc Med 2007; 17(4):113-8. (Pubitemid 46670020)